These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25572299)

  • 1. Severe rectal complications after prostate brachytherapy.
    Wallner K; Sutlief S; Bergsagel C; Merrick GS
    Radiother Oncol; 2015 Feb; 114(2):272-5. PubMed ID: 25572299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
    Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer.
    Gelblum DY; Potters L
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):119-24. PubMed ID: 10924980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer.
    Orio PF; Merrick GS; Galbreath RW; Butler WM; Lief J; Wallner KE
    Brachytherapy; 2012; 11(5):341-7. PubMed ID: 22561216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding.
    Mueller A; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1047-52. PubMed ID: 15234038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal Ulcers and Rectoprostatic Fistulas after (125)I Low Dose Rate Prostate Brachytherapy.
    Leong N; Pai HH; Morris WJ; Keyes M; Pickles T; Tyldesley S; Wu J;
    J Urol; 2016 Jun; 195(6):1811-6. PubMed ID: 26778712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.
    Sherertz T; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W; True L
    Brachytherapy; 2004; 3(3):130-5. PubMed ID: 15533804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
    Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: With or without supplemental external beam radiotherapy.
    Serrano N; Moghanaki D; Asher D; Karlin J; Schutzer M; Chang M; Hagan MP
    Brachytherapy; 2016; 15(4):435-441. PubMed ID: 27180124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of rectal toxicity after permanent iodine-125 seed implantation: Prospective cohort study in 2339 patients.
    Katayama N; Yorozu A; Maruo S; Kojima S; Ohashi T; Tanaka N; Kikuchi T; Higashide S; Saito S; Dokiya T; Fukushima M; Yamanaka H
    Brachytherapy; 2016; 15(6):736-745. PubMed ID: 27720311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.
    Nguyen PL; Devlin PM; Beard CJ; Orio PF; O'Leary MP; Wolfsberger LD; O'Farrell DA; Sweeney CM; Hadaschik BA; Hohenfellner M; Hatiboglu G
    Brachytherapy; 2013; 12(1):77-83. PubMed ID: 22543116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate cancer.
    Gokhale AS; Beriwal S; Smith RP; Li X; Benoit R
    Brachytherapy; 2010; 9(4):328-34. PubMed ID: 20116341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis.
    Kalakota K; Rakhno E; Pelizzari CA; Jani AB; Liauw SL
    Brachytherapy; 2010; 9(2):131-6. PubMed ID: 19853533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late rectal toxicity.
    Chicas-Sett R; Farga D; Perez-Calatayud MJ; Celada F; Roldan S; Fornes-Ferrer V; Ibanez-Rosello B; Tormo A; Benlloch JM; Perez-Calatayud J
    Brachytherapy; 2017; 16(3):511-517. PubMed ID: 28366276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion.
    Ellis RJ; Zhou H; Kaminsky DA; Fu P; Kim EY; Sodee DB; Colussi V; Spirnak JP; Whalen CC; Resnick MI
    Brachytherapy; 2007; 6(2):149-56. PubMed ID: 17434109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of rectal bleeding following I-125 prostate brachytherapy.
    Hu K; Wallner K
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):263-5. PubMed ID: 9607339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure.
    Bittner N; Wallner K; Merrick G; Orio P; Nurani R; True L
    Am J Clin Oncol; 2008 Jun; 31(3):231-6. PubMed ID: 18525300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.